<--- Back to Details
First PageDocument Content
Date: 2015-02-04 05:15:01

PRESS RELEASE – PRESSEINFORMATION GANYMED raises EUR 14.4 million in Series B Financing Round Mainz, Germany (July 06, 2005) – GANYMED Pharmaceuticals AG, a privately held antibody development company with a focus o

Add to Reading List

Source URL: www.ganymed-pharmaceuticals.com

Download Document from Source Website

File Size: 45,77 KB

Share Document on Facebook

Similar Documents